Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates throu...
Q3 2026
Jul 15, 2026
Q2 2026
Apr 10, 2026
Q1 2026
Jan 9, 2026
FY 2025
Oct 22, 2025
Q4 2025